We’re excited to share that the European Commission has approved our treatment for non-Central Nervous System manifestations of #ASMD in pediatric and adult patients with ASMD type A/B or type B. - The ASMD community has proven its strength, and we recognize their continued perseverance! - #Sanofi #WeNeverSettle #raredisease #rarediseases #niemannpick